Covenant Asset Management, LLC Abb Vie Inc. Transaction History

Covenant Asset Management, LLC

$610 Million
Q1 2024

A detailed history of Covenant Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Covenant Asset Management, LLC holds 25,837 shares of ABBV stock, worth $4.29 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

25,837

Previous 24,617 4.96%

Holding current value

$4.29 Million

Previous $3.81 Million 23.34%

% of portfolio

0.77%

Previous 0.69%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $194,980 - $222,162	1,220 Added 4.96%	25,837 $4.7 Million
Q4 2023 Jan 22, 2024	SELL	$137.6 - $154.97 $174,201 - $196,192	-1,266 Reduced 4.89%	24,617 $3.81 Million
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $10,152 - $11,753	-76 Reduced 0.29%	25,883 $3.86 Million
Q2 2023 Jul 12, 2023	SELL	$132.51 - $164.9 $795 - $989	-6 Reduced 0.02%	25,959 $3.5 Million
Q1 2023 Apr 27, 2023	BUY	$144.61 - $166.54 $105,131 - $121,074	727 Added 2.88%	25,965 $4.14 Million

Q4 2022 Jan 24, 2023	BUY	$138.31 - $165.87 $67,910 - $81,442	491 Added 1.98%	25,238 $0
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $10,065 - $11,544	75 Added 0.3%	24,747 $3.32 Million
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $32,891 - $41,815	239 Added 0.98%	24,672 $3.78 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $11,218 - $13,918	-85 Reduced 0.35%	24,433 $3.96 Million
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $9,990 - $12,641	-93 Reduced 0.38%	24,518 $3.32 Million
Q3 2021 Oct 15, 2021	SELL	$106.4 - $120.78 $29,153 - $33,093	-274 Reduced 1.1%	24,611 $2.66 Million
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $33,247 - $36,601	325 Added 1.32%	24,885 $2.69 Million
Q4 2020 Jan 28, 2021	BUY	$80.49 - $108.67 $83,307 - $112,473	1,035 Added 4.4%	24,560 $2.63 Million
Q3 2020 Oct 29, 2020	BUY	$85.91 - $100.83 $50,257 - $58,985	585 Added 2.55%	23,525 $2.06 Million
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $20,763 - $27,784	283 Added 1.25%	22,940 $2.25 Million
Q1 2020 Apr 22, 2020	BUY	$64.5 - $97.79 $80,689 - $122,335	1,251 Added 5.84%	22,657 $1.73 Million
Q4 2019 Jan 24, 2020	SELL	$72.13 - $90.25 $10,098 - $12,635	-140 Reduced 0.65%	21,406 $1.9 Million
Q3 2019 Oct 18, 2019	SELL	$62.98 - $75.72 $15,745 - $18,930	-250 Reduced 1.15%	21,546 $1.63 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $14,454 - $18,475	220 Added 1.02%	21,796 $1.59 Million
Q1 2019 Apr 26, 2019	SELL	$77.14 - $90.79 $71,123 - $83,708	-922 Reduced 4.1%	21,576 $1.74 Million
Q3 2018 Oct 09, 2018	SELL	$88.91 - $98.84 $44,010 - $48,925	-495 Reduced 2.15%	22,498 $2.13 Million
Q2 2018 Jul 12, 2018	BUY	$89.78 - $106.23 $31,871 - $37,711	355 Added 1.57%	22,993 $2.13 Million
Q1 2018 May 04, 2018	BUY	$92.01 - $123.21 $25,026 - $33,513	272 Added 1.22%	22,638 $2.14 Million
Q4 2017 Jan 12, 2018	BUY	$89.56 - $98.21 $21,763 - $23,865	243 Added 1.1%	22,366 $2.16 Million
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $1.55 Million - $1.97 Million	22,123	22,123 $1.97 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Asset Management, LLC with notifications on news.

Account

Covenant Asset Management, LLC Abb Vie Inc. Transaction History